Home Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck
 

Keywords :   


Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck

2014-01-13 07:51:19| Biotech - Topix.net

Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today the acquisition of Merck's wholly owned subsidiary Sirna Therapeutics, Inc. , comprising intellectual property and RNAi assets including pre-clinical therapeutic candidates, chemistry, siRNA-conjugate and other delivery technologies.

Tags: assets therapeutic acquires merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »